# A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid Arthritis

> **NCT00042068** · PHASE3 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 1000 (—)

## Conditions studied

- Arthritis, Rheumatoid

## Interventions

- **DRUG:** Meloxicam

## Key facts

- **NCT ID:** NCT00042068
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06
- **Primary completion:** —
- **Final completion:** 2003-07
- **Target enrollment:** 1000 (—)
- **Last updated:** 2013-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00042068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00042068, "A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00042068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*